A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

Summary

This phase I study will determine the pharmacokinetic profile of patupilone in patients with mild or moderately impaired hepatic function within 2 cycles of treatment. The study population for this trial consists of patients with a documented advanced solid tumor. Patients will be stratified into 3 groups: those with normal liver function, and those with mild or moderate liver dysfunction.

Timeline

Start

2006-01

Primary completion

2010-07

Completion

—

Drugs

Indications